{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/64850-511#drug","name":"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"64850-511"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA212037"},{"@type":"PropertyValue","propertyID":"UNII","value":"6DPV8NK46S|O1ZPV620O4|JJ768O327N|G83415V073"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"084c625c-94c6-4c8a-ba5f-6e26206dd903"}],"activeIngredient":"AMPHETAMINE ASPARTATE MONOHYDRATE, AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, DEXTROAMPHETAMINE SULFATE","administrationRoute":["ORAL"],"dosageForm":"CAPSULE, EXTENDED RELEASE","manufacturer":{"@type":"Organization","name":"Elite Laboratories, Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA212037","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=084c625c-94c6-4c8a-ba5f-6e26206dd903","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64850-511"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-31T10:37:25.077Z"}}